UBS Group AG - MELINTA THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

MELINTA THERAPEUTICS INC's ticker is MLNTXXXX and the CUSIP is 58549G100. A total of 79 filers reported holding MELINTA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.60 and the average weighting 0.7%.

Links
Filings
External links
Quarter-by-quarter ownership
UBS Group AG ownership history of MELINTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$11,000
-79.2%
13,890
+4.1%
0.00%–
Q3 2018$53,000
+96.3%
13,347
+218.0%
0.00%–
Q2 2018$27,000
+107.7%
4,197
+139.3%
0.00%–
Q1 2018$13,000
-78.0%
1,754
-53.7%
0.00%–
Q4 2017$59,000–3,787–0.00%–
 Download
Other shareholders
MELINTA THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
ISTHMUS PARTNERS, LLC 84,072$7,657,0001.86%
Sterling Investment Advisors, Ltd. 19$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of MELINTA THERAPEUTICS INC shareholders